![Jun Hui Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 61 M $ op 30-09-2026
Jun Hui Liu is currently the President & Director at Yunnan Oriental Anti-Aging Biotechnology Co. Ltd. He previously worked as a Director at Walvax Biotechnology Co., Ltd. and as a Member-Supervisory Board at Beijing ChinaEquity Investment Co., Ltd.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-09-2025 | 28.933.000 ( 1,86% ) | 61 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Yunnan Oriental Anti-Aging Biotechnology Co. Ltd. | President | 05-01-2012 |
| Bedrijven | Functie | Einde |
|---|---|---|
Beijing ChinaEquity Investment Co., Ltd.
 Beijing ChinaEquity Investment Co., Ltd. Investment ManagersFinance Operates as venture capital and private equity firm | Directeur/Bestuurslid | - |
| WALVAX BIOTECHNOLOGY CO., LTD. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Walvax Biotechnology Co., Ltd.
 Walvax Biotechnology Co., Ltd. BiotechnologyHealth Technology Engages in the research and development, production, and sale of human vaccine products | Health Technology |
Yunnan Oriental Anti-Aging Biotechnology Co. Ltd. | |
Beijing ChinaEquity Investment Co., Ltd.
Beijing ChinaEquity Investment Co., Ltd. Investment ManagersFinance Operates as venture capital and private equity firm | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau
